Why Data-Driven Success Demands More Than Quick Wins With Vikas Mahajan

While the quick wins are valuable, they should be part of a bigger ecosystem that scales with the use cases.
The pharmaceutical industry is undergoing a significant transformation, fueled by the integration of AI and data-driven technologies. These innovations hold the promise of revolutionizing everything from personalized medicine to drug discovery and patient engagement. However, amidst the excitement surrounding these advancements, leaders must be cautious of the risks posed by jumping into AI adoption without fully understanding its potential or limitations. In this interview, Vikas Mahajan, Head of Data and Analytics at Indegene, offers valuable insights on how pharmaceutical organizations can navigate the complexities of AI, avoid common pitfalls, and ensure that their AI investments align with long-term business goals. With over 20 years of experience in data strategy, AI, and machine
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Anshika Mathews
Anshika Mathews
Anshika is the Senior Content Strategist for AIM Research. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.